Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2019 2
2020 2
2022 2
2023 1
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Causal Inference in Oncology: Why, What, How and When.
van Amsterdam WAC, Elias S, Ranganath R. van Amsterdam WAC, et al. Clin Oncol (R Coll Radiol). 2025 Feb;38:103616. doi: 10.1016/j.clon.2024.07.002. Epub 2024 Jul 11. Clin Oncol (R Coll Radiol). 2025. PMID: 39122629 Free article. Review.
Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.
Schuiveling M, Ter Maat LS, Van Duin IAJ, Verheijden RJ, Troenokarso MF, Moeskops P, Verhoeff JJC, Elias SG, Van Amsterdam WAC, Burgers F, Van Den Berkmortel FWPJ, Boers-Sonderen MJ, Boomsma MF, De Groot JW, Haanen JBAG, Hospers GAP, Piersma D, Vreugdenhil G, Westgeest HM, Kapiteijn E, Labots M, Veldhuis WB, Van Diest PJ, De Jong PA, Pluim JPW, Leiner T, Veta M, Suijkerbuijk KPM. Schuiveling M, et al. Among authors: van amsterdam wac. J Natl Cancer Inst. 2025 Feb 21:djaf039. doi: 10.1093/jnci/djaf039. Online ahead of print. J Natl Cancer Inst. 2025. PMID: 39980388
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma.
van Duin IAJ, Schuiveling M, Ter Maat LS, van Amsterdam WAC, van den Berkmortel F, Boers-Sonderen M, de Groot JWB, Hospers GAP, Kapiteijn E, Labots M, Piersma D, Schrader AMR, Vreugdenhil G, Westgeest H, Veta M, Blokx WAM, van Diest PJ, Suijkerbuijk KPM. van Duin IAJ, et al. Among authors: van amsterdam wac. Eur J Cancer. 2024 Sep;208:114190. doi: 10.1016/j.ejca.2024.114190. Epub 2024 Jun 30. Eur J Cancer. 2024. PMID: 38991284 Free article.
Risk-Based Decision Making: Estimands for Sequential Prediction Under Interventions.
Luijken K, Morzywołek P, van Amsterdam W, Cinà G, Hoogland J, Keogh R, Krijthe JH, Magliacane S, van Ommen T, Peek N, Putter H, van Smeden M, Sperrin M, Wang J, Weir DL, Didelez V, van Geloven N. Luijken K, et al. Among authors: van amsterdam w. Biom J. 2024 Dec;66(8):e70011. doi: 10.1002/bimj.70011. Biom J. 2024. PMID: 39607308 Free PMC article.
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma.
Ter Maat LS, De Mooij RAJ, Van Duin IAJ, Verhoeff JJC, Elias SG, Leiner T, van Amsterdam WAC, Troenokarso MF, Arntz ERAN, Van den Berkmortel FWPJ, Boers-Sonderen MJ, Boomsma MF, Van den Eertwegh FJM, de Groot JW, Hospers GAP, Piersma D, Vreugdenhil A, Westgeest HM, Kapiteijn E, De Wit AA, Blokx WAM, Van Diest PJ, De Jong PA, Pluim JPW, Suijkerbuijk KPM, Veta M. Ter Maat LS, et al. Among authors: van amsterdam wac. Sci Rep. 2024 Dec 30;14(1):31668. doi: 10.1038/s41598-024-81188-2. Sci Rep. 2024. PMID: 39738216 Free PMC article.
15 results